文献速递睡眠呼吸障碍咽喉与嗓音

阻塞性睡眠呼吸暂停患者的口唇闭合与气流:一项非随机临床试验

Mouth Closure and Airflow in Patients With Obstructive Sleep Apnea: A Nonrandomized Clinical Trial.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2024-01-01

该非随机临床试验纳入54例经药物诱导睡眠内镜确诊的阻塞性睡眠呼吸暂停患者,按口腔气流水平分3个分位数,闭合口唇后整体吸气总流量增加27.8个百分点(β=1.0 L/min,95%CI 0.4-1.9),但近零口腔呼吸组无关联、中等口腔呼吸组改善、高水平口腔呼吸组反而恶化,腭咽阻塞与闭合口唇后气流减少相关。

要点

  • 闭合口唇使整体吸气总流量增加27.8个百分点(β=1.0 L/min,95%CI 0.4-1.9)。
  • 高水平口腔呼吸组闭合口唇后气流恶化(-1.9 L/min,95%CI -3.1至-0.6)。
  • 腭咽阻塞与口腔呼吸增加(0.6 L/min,95%CI 0.1-3.0)及闭合口唇后气流减少(-1.9 L/min,95%CI -3.1至-0.7)相关。

核心结论

  • 在该非随机临床试验整体队列中,闭合口唇增加吸气气流,但结局存在异质性。
  • 对于睡眠时主要经口呼吸且存在腭咽阻塞的患者,闭合口唇后气流恶化。
  • 因此,作者认为应考虑对口腔呼吸采取个体化治疗方法。

研究设计与样本

  • 非随机临床试验,纳入经药物诱导睡眠内镜确诊的阻塞性睡眠呼吸暂停患者。
  • 按口腔呼吸水平分3个分位数:分位数1为口腔气流<0.05 L/min,分位数2为0.05-2.2 L/min,分位数3为>2.2 L/min。
  • 干预为睡眠中交替呼吸时对颏部施加压力至牙齿咬合以闭合口唇。
  • 共入组66例,排除12例基线气流不足,分析队列54例(39例[72%]男性;中位[IQR]年龄55[46-64]岁;呼吸暂停低通气指数26.9[17.6-39.9]次/小时;体重指数28.9[27.1-31.6])。

主要发现

  • 闭合口唇使整体吸气总流量增加27.8个百分点(β=1.0 L/min,95%CI 0.4-1.9)。
  • 近零口腔呼吸的10例患者无关联(0.9 L/min,95%CI -0.2至2.1)。
  • 中等口腔呼吸的32例患者闭合口唇后气流改善(2.0 L/min,95%CI 1.3-2.7)。
  • 高水平口腔呼吸患者闭合口唇后气流恶化(-1.9 L/min,95%CI -3.1至-0.6)。
  • 腭咽阻塞与口腔呼吸增加(0.6 L/min,95%CI 0.1-3.0)及闭合口唇后气流减少(-1.9 L/min,95%CI -3.1至-0.7)相关。

临床怎么用

  • 原文结论认为,对口腔呼吸应采取个体化治疗方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Mouth breathing is associated with increased airway resistance, pharyngeal collapsibility, and obstructive sleep apnea (OSA) severity. The common belief is that closing the mouth can mitigate the negative effects of mouth breathing during sleep. However, mouth breathing may serve as an essential route to bypassing obstruction along the nasal route (eg, the velopharynx). OBJECTIVE: To investigate the role of mouth breathing as an essential route in some patients with OSA and its association with upper airway anatomical factors. DESIGN, SETTING, AND PARTICIPANTS: This nonrandomized clinical trial included participants diagnosed with OSA who underwent drug-induced sleep endoscopy. Patients were stratified into 3 quantiles based on oral-breathing level (quantile 1: oral airflow < 0.05 L/min; quantile 2: oral airflow 0.05-2.2 L/min; quantile 3: oral airflow > 2.2 L/min). INTERVENTIONS: Closing the mouth during sleep during alternating breaths by applying pressure to the mentum until teeth are in occlusion. MAIN OUTCOMES AND MEASURES: The primary outcome was total inspiratory flow defined as the change in airflow in the transition from mouth relaxed to mouth closed, analyzed overall and by 3 oral-breathing quantiles. The association of velopharyngeal obstruction on the change in total inspiratory airflow was also investigated. RESULTS: Of 66 enrolled patients with OSA, 12 were excluded due to insufficient baseline airflow. The analytic cohort consisted of 54 patients (39 [72%] male; median [IQR] age, 55 [46-64] years; apnea-hypopnea index, 26.9 [17.6-39.9] events/h; and body mass index calculated as weight in kilograms divided by height in meters squared, 28.9 [27.1-31.6]). Mouth closure increased total inspiratory flow by 27.8 percentage points overall (β, 1.0 [95% CI, 0.4-1.9] L/min). However, outcomes varied based on the degree of baseline oral breathing. No association was found for 10 patients with near-zero mouth breathing (0.9 [95% CI, -0.2 to 2.1] L/min). Airflow improved with mouth closure in 32 patients with moderate levels of mouth breathing (2.0 [95% CI, 1.3-2.7] L/min), whereas it worsened in patients with high levels of mouth breathing (-1.9 [95% CI, -3.1 to -0.6] L/min). Velopharyngeal obstruction was associated with increased mouth breathing (0.6 [95% CI, 0.1-3.0] L/min) and reduced airflow with mouth closure (-1.9 [95% CI, -3.1 to -0.7] L/min). CONCLUSION AND RELEVANCE: Although mouth closure increased inspiratory airflow in the overall cohort of this nonrandomized clinical trial, the outcomes were heterogeneous. In patients who breathe primarily through their mouth during sleep and have velopharyngeal obstruction, airflow worsens with mouth closure. Hence, personalized approaches to treating mouth breathing should be considered. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT06547658.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Yang H, Huyett P, Wang TY, et al. Mouth Closure and Airflow in Patients With Obstructive Sleep Apnea: A Nonrandomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2024. PMID: 39361293. doi:10.1001/jamaoto.2024.3319

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。